FINALS LEC: Molecular Detection of Inherited Diseases Flashcards

1
Q

Caused by mutations (changes) in germ cells that are passed down from parent to child

A

Inherited Diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mutations in Somatic Cell

A
  1. Cancer
  2. Congenital malformations (present at birth): due to factors upsetting the developmental process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Abnormal chromosome #

A

Genome Mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

more than 2 sets

A

Polyploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

gain (trisomy)/loss (monosomy)

A

Aneuploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Detection for genome mutations:

A

karyotyping, ploidy analysis, flow cytometry, & FISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Flat facial profile, mental retardation, cardiac problems. risk of acute leukemia, eventual neuropathological disorders, abnormal immune system

A

down syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Severe, clenched fist; survival less than 1 year

A

edward syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cleft palate, heart damage, mental retardation, survival usually less than 6 mo

A

patau syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Male hypogonadism, long legs, gynecomastia (male breast enlargement), low testosterone level

A

klinefelter syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Excessive height, acne, 1%-2% behavioral disorders

A

XYY SYNDROME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bilateral neck webbing, heart disease, failure to develop secondary sex characteristics, hypothyroidism

A

turner syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mental retardation increases with increasing X

A

Multi X females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Trisomy 21, 47,XY+21

A

Down syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Trisomy 18, 47,XY+18

A

Edward syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Trisomy 13, 47,XY+13

A

Patau syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

47,XXY

A

Klinefelter syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

47,XYY

A

XYY SYNDROME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

45X and variants

A

turner syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

47,XXX: 48,XXXX

A

Multi X females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Abnormalities in chromosome structure

A

Translocations, inversions, deletions, duplications, marker chromosomes, derivative chromosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

caused by chemicals, radiation, chromosome breakage syndromes (Fanconi anemia, Bloom syndrome, ataxia telangiectasia)

A

Chromosome breakage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chromosomal mutations detection

A

karyotyping, FISH, microarray technology (CGH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CATCH 22 (cardiac abnormality/abnormal facies, T-cell deficit, cleft palate, hypercalcemia)

A

DiGeorge syndrome and velocardiofacial syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Growth deficiency, catlike cry in infancy, small head, mental retardation
Cri du chat syndrome
26
Aniridia (absence of iris), hemihypertrophy (one side of the body seems to grow faster than the other), and other congenital anomalies.
Contiguous gene syndrome; Wilms tumor, aniridia, genitourinary anomalies, mental retardation syndrome
27
del(22q)
Cri du chat syndromeDiGeorge syndrome and velocardiofacial syndrome
28
del(5p)
Cri du chat syndrome
29
del (11p)
Contiguous gene syndrome; Wilms tumor, aniridia, genitourinary anomalies, mental retardation syndrome
30
Single-gene diseases affect structural proteins, cell surface receptor proteins, growth regulators, and enzymes
Patterns of Inheritance in Single-Gene Diseases
31
3 Dominance Relationships
Complete dominance Partial/incomplete dominace Codominance
32
 Heterozygous phenotype (child=Tt)  Homozygous phenotype (1 parent = TT)  Example: height
Complete dominance
33
 Offspring phenotype is variably intermediate (combine) between the homozygous & heterozygous parentals  Example: gene affecting hair texture
Partial/incomplete dominance
34
 Simultaneously demonstrate the phenotype of both parents  Example: ABO blood group
Codominance
35
Dominant allele will mask the effect of the recessive allele completely
Complete Dominance
36
Both the alleles are dominant
Codominance
37
A.K.A. transmission patterns/mode of inheritance
Patterns of Inheritance in Single-Gene Diseases
38
 The manner in which a genetic trait, disorder, or risk of disorder is passed from one generation to the next  Determined by examination of family histories
Patterns of Inheritance in Single-Gene Diseases
39
diagram of family phenotype/genotype
Pedigree
40
Patterns of Inheritance in Single-Gene Disease 3 main patterns:
autosomal dominant, autosomal recessive, sex-linked (Xlinked)
41
 Criteria: 1. Males and females can be affected. Male-to-male transmission may occur. 2. Males and females transmit the trait with equal frequency. RECESSIVE DOMINANT 3. Successive generations are affected. 4. Transmission stops after a generation in which no one inherits the mutation.  Affected individual: has dominant allele  Parent 1 (affected) x Parent (2) (unaffected) = 50%-100% risk/likelihood of expressing the disease phenotype on the child
Autosomal Dominant Transmission
42
 Criteria: 1. Males and females can be affected. 2. Affected males and females can transmit the gene, unless it causes death before reproductive age. 3. The trait can skip generations. 4. Parents of an affected individual are heterozygous or have the traits  Affected individual: homozygous recessive genotypes  Carriers: heterozygotes/ asymptomatic
Autosomal Recessive Transmission
43
Sex-Linked Transmission
X-linked recessive transmission X-linked dominant transmission
44
 Common  Always expressed in males  Inherit the trait from heterozygote/homozygote mother  Females are carriers and can only be expressed if the causative allele is present in 2 copies  Inherit the trait from affected father & affected heterozygote mother  Ichthyosis, colorblindness, hemophilia
X-linked recessive transmission
45
 Rare  Always expressed in females  Passed from male to all daughters but to no sons  Expressed also in males, with more severe effects  Rickets, Rett syndrome, incontinentia pigmenti, congenital hypertrichosis
X-linked dominant transmission
46
Freq. of expression of disease phenotype in individuals with a gene lesion
Penetrance
47
homozygous recessive
Complete penetrance
48
 Range of phenotypes in individuals with the same gene lesion  Example: polydactyly
Variable expressivity
49
Detection: Molecular methods, morphological studies, clinical chemistry Final diagnosis: physiological, morphological, & laboratory results
Single-Gene Disorders
50
 Cause: incompletely digested macromolecules due to loss of enzymatic degradation (acid hydrolases)  Defects in proteins required for normal lysosomal function  physical abnormalities  Screening: gene product testing  Molecular testing: genes that code for the enzymes & their subunits  Detection of mutation: direct sequencing
Lysosomal Storage Disease
51
 Cause: Single point mutation in the coagulation factor V gene F5 (1q23) at exon 10 (1691G>A, R506Q)  Genotype: heterozygous form (4%8% of the general population) & homozygous (0.06%-0.25%)  Thrombophilia: inherited blood clotting disorder  Treatment for blood clot/deep venous thrombosis: anticoagulants  Molecular methods: PCR-RFLP, SSP-PCR  Other methods: Invader technology, clot-based methods, family history
Factor V Leiden
52
 Precursor to thrombin in the coagulation cascade  Autosomal-dominant increased risk of thrombosis: mutation in the 3’ untranslated region of the gene that codes for prothrombin or coagulation factor II, F2 (11p11-q12)x  Laboratory tests: F2 & F5 mutations  Molecular methods: multiplex PCRRFLP  Phenotypic methods: thrombin time, prothrombin time, platelet count, CBC  Automated systems: measure changes in light transmittance during clot formation generating a curve  Other: sequencing of factors XI & XIII
Prothrombin
53
autosomal recessive disorder caused by deficiency of the 5,10methylenetetrahydrofolate reductase (MTHFR) gene product
Hyperhomocysteinemia
54
 Genetic alterations: 677C>T (p.A222V) & 1298A>C (p.E429A)  deficiencies in folate metabolism  Detection: standard/multiplex PCR with RFLP (HinfI & MboII) or sequencing, multiplex qPCR, HR-MCA
Methylenetetrahydrofolate Reductase
55
 Autosomal recessive condition, overabsorption of iron from food  pancreas, liver, & skin damage; heart disease; diabetes  Diagnosis: measurement of blood iron levels, transferrin saturation, liver biopsy  Molecular cause: dysfunction of the hemochromatosis type I HFE or HLAH gene product (C282Y, H63D, S65C)  Indications for mutation testing: clinical symptoms & increased serum ferritin & transferrin-iron saturation  C282Y mutation detection: PCRRFLP
Hemochromatosis
56
 Life-threatening autosomal recessive disorder that causes severe lung damage & nutritional deficiencies  Affects cells that produces mucus, sweat, saliva, & digestive juices  secretions become thick & sticky  Cause: loss of function of the CFTR gene (3-bp deletion F508del & 1,900 other mutations such as G542X, G551D, N1301K, R117H, W1282X, 1717-1G>A) (Human Genome Variation Society www.genet.sickkids.on.ca)  Molecular tests for mutation detection: RFLP, PCR-RFLP, HA, temporal-gradient gel electrophoresis, SSCP, SSP-PCR, cleavase, bead array technology, & direct sequencing
Cystic Fibrosis
57
 Group of mono-oxygenase enzymes localized to the ER  Present in high concentrations in the liver & small intestine  enzymes metabolize & detoxify compounds (drugs)  Polymorphisms affect the metabolism of hormones, caffeine, chemotherapeutic drugs, antidepressants, & oral contraceptives:  Tests are used to predict the response to drugs  Detection of polymorphisms: allele -specific PCR  Screening tests: microarray, bead array, sequencing
Cytochrome P-450
58
Do not follow Mendelian rules of inheritance:
 Mitochondrial gene mutations  Genomic imprinting  Gonadal mosaicism  Nucleotide-repeat expansion disorders  Multifactorial inheritance
59
 Maternally inherited  mtDNA  Circular, 16,569 bp, with 37 genes, 1000-nt control region  Database of mt genes & mutations: http://www.MITOMAP.org  Mutations affect energy production  muscles & nervous system  Heteroplasmy: mutated mt & normal mt in the same cell  Molecular methods:  Large deletions: Southern blot  Point mutations: PCR-RFLP
Mitochondrial (mt) Gene Mutations
60
 Only 1 copy of a gene in an individual (either from mother or father) is expressed, while the other copy is suppressed  Example: mules (male donkey x female horse) & hinnies (male horse x female donkey)  Cause: transcriptionally silencing through histone/DNA modification  Genetic disorders: 1 or other allele of a gene is lost (uniparental disomy)  Examples: 1. Prader-Willi syndrome: paternal del(15)(q11q13) 2. Angelman syndrome: same region, maternal
Genomic Imprinting
61
Cytogenetic methods:
 Translocations & some deletions: standard karyotyping  Microdeletions: HR-karyotyping  FISH with labeled probes
62
Molecular methods:
 PCR-RFLP/STR analysis  Methylation-specific PCR  Southern blot using methylation-specific restriction enzymes  Assays developed for CNV detection: FISH, array-based CGH, NGS
63
 Generation of new mutations in germline cells  giving rise to eggs/sperm carrying the mutation which then becomes a heritable phenotype  Expected when phenotypically normal parents have more than 1 affected child  Example: osteogenesis imperfecta
Gonadal Mosaicism
64
 Nucleotide repeats, such as STRs (1-10 bp repeating units) can expand in length during DNA replication & meiosis  Triplet-repeat mutations: expansions of STR w/ 3-bp repeating units in the gene sequences  Fragile X syndrome  Huntington disease  Idiopathic congenital central hypoventilation syndrome (CCHS)
Nucleotide-Repeat Expansion Disorder
65
 CGG expansion (up to >2,000 repeats) in the noncoding region 5’ to the FMR-1 gene  Symptoms (increase in severity with each generation): learning disorders & mental retardation (IQ~20), long face, large ears, macroorchidism  Detection:  Karyotyping  PCR  Southern blot  Capillary electrophoresis
Fragile X Syndrome
66
 CAG expansion (9-37 repeats to 3886 repeats) in the huntingtin structural gene (4p16.3)  Symptoms: impaired judgment, slurred speech, difficulty in swallowing, chorea, personality changes, depression, mood swings, unsteady gait, intoxicated appearance  Detection: standard PCR methods, capillary electrophoresis
Huntington Disease
67
 Gene mutations in PHOX2b gene in chromosome 4: insertion of multiple alanine residues  Inadequate breathing while asleep, hypoventilation while awake  Occurs in association with an intestinal disorder (Hirschsprung disease) & symptoms of ANS dysregulation/dysfunction  Detection:  PCR w/ 32P-labeled primer & polyacrylamide gel electrophoresis  Standard PCR & agarose gel electrophoresis
Idiophatic Congenital Central Hypoventilation Syndrome (CCHS)
68
 Disorders (& normal conditions) controlled by multiple genetic & environmental factors (nutritional/chemical exposures)  Phenotypes: conditioned by the no. of controlling genes inherited  Detection:  HR-array methods  NGS  Interpretation:  Databases (ClinVar & dbSNP)  Prognostic & diagnostic value of gene mutation analysis:  Annotation of demographics (ethnicity/gender, lifestyles)
Multifactorial Inheritance
69
 Phenotypic methods: treatment is directed to the phenotype  Genes with variable expressivity  Gene mutation may not predict the severity of the phenotype  Clotting time & transferrin saturation  Better guides for anticoagulant treatment  Molecular testing  May discover genetic lesions in the absence of symptoms  Offer only a diagnosis, not a cure
Limitations of Molecular Testing
70
Lysosomal Storage Disease screening:
gene product testing
71
Lysosomal Storage Disease molecular testing:
genes that code for the enzymes & their subunits
72
Lysosomal Storage Disease Detection of mutation:
direct sequencing
73
inherited blood clotting disorder
Thrombophilia
74
Treatment for blood clot/deep venous thrombosis:
anticoagulants
75
Molecular methods of Factor V Leiden:
PCR-RFLP, SSP-PCR
76
Autosomal-dominant increased risk of thrombosis:
mutation in the 3’ untranslated region of the gene that codes for prothrombin or coagulation factor II, F2 (11p11-q12)x
77
Laboratory tests for prothrombin:
F2 & F5 mutations
78
Molecular methods of prothrombin:
multiplex PCR-RFLP
79
Phenotypic methods of prothrombin:
thrombin time, prothrombin time, platelet count, CBC
80
Automated systems of prothrombin:
measure changes in light transmittance during clot formation generating a curve
81
Detection of Methylenetetrahydrofolate Reductase:
standard/multiplex PCR with RFLP (HinfI & MboII) or sequencing, multiplex qPCR, HR-MCA
82
C282Y mutation detection:
PCR-RFLP
83
Molecular tests for mutation detection of cystic fibrosis:
RFLP, PCR-RFLP, HA, temporal-gradient gel electrophoresis, SSCP, SSP-PCR, cleavase, bead array technology, & direct sequencing
84
Detection of polymorphisms for Cytochrome P-450:
allele -specific PCR
85
Screening tests for Cytochrome P-450:
microarray, bead array, sequencing
86
Mutations affect energy production
muscles & nervous system
87
Mutations affect energy production
muscles & nervous system
88
mutated mt & normal mt in the same cell
Heteroplasmy
89
Molecular methods for mitochondrial gene mutations:  Large deletions:  Point mutations:
Southern blot , PCR-RFLP
90
Cause: transcriptionally silencing through histone/DNA modification
Genomic Imprinting
91
Examples: 1. Prader-Willi syndrome: paternal del(15)(q11q13) 2. Angelman syndrome: same region, maternal
Genomic Imprinting
92
Expected when phenotypically normal parents have more than 1 affected child
Gonadal Mosaicism
93
expansions of STR w/ 3-bp repeating units in the gene sequences
Triplet-repeat mutations
94
Symptoms (increase in severity with each generation): learning disorders & mental retardation (IQ~20), long face, large ears, macroorchidism
Fragile X Syndrome
95
Symptoms: impaired judgment, slurred speech, difficulty in swallowing, chorea, personality changes, depression, mood swings, unsteady gait, intoxicated appearance
Huntington Disease
96
Inadequate breathing while asleep, hypoventilation while awake  Occurs in association with an intestinal disorder (Hirschsprung disease) & symptoms of ANS dysregulation/dysfunction
Idiophatic Congenital Central Hypoventilation Syndrome (CCHS)